These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2150634)

  • 21. The natriuretic effect of the dihydropyridine calcium antagonist felodipine: a placebo-controlled study involving intravenous angiotensin II in normotensive volunteers.
    Sluiter HE; Wetzels JF; Huysmans FT; Koene RA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S154-61. PubMed ID: 2455121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does the diuretic effect of calcium inhibitors play an important role in the hypertensive efficacy?].
    Maldonado Martin A; Gil Extremera B; Rubio Luengo MA
    Presse Med; 1995 Apr; 24(14):686-90. PubMed ID: 7770417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacological properties of lipophilic calcium antagonists.
    van Zwieten PA
    Blood Press Suppl; 1998; 2():5-9. PubMed ID: 9850436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists and the kidney.
    Epstein M
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity.
    Hof RP; Rüegg UT
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):107S-113S. PubMed ID: 1826999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide (ANP) in chronic obstructive pulmonary disease (COPD): the relationship between plasma ANP and lung function. Effects of exercise and of the calcium antagonist, isradipine, on plasma ANP. A randomised, double-blind, placebo-controlled study.
    Graudal N; Galløe AM; Storm T; Thamsborg G; Christensen HR
    Horm Metab Res; 1992 Mar; 24(3):130-3. PubMed ID: 1533606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and counterregulatory effects of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Müller FB; Bühler FR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S39-43. PubMed ID: 2468904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of isradipine and other calcium antagonists on arteriovenous-shunt flow in anesthetized rabbits and cats.
    Hof RP
    Am J Med; 1989 Apr; 86(4A):40-9. PubMed ID: 2523654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of isradipine (Lomir, Sandoz) on coronary insufficiency during the esophageal stimulation stress test].
    Vainer J; Mádle A; Cepelák V; Brunát J; Smíd J
    Vnitr Lek; 1991 Mar; 37(3):242-7. PubMed ID: 1827692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive therapy with isradipine in patients with special safety concerns.
    Blecker D
    Angiology; 1994 Dec; 45(12):997-1008. PubMed ID: 7985835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discussion on the natriuretic effect of calcium antagonists.
    Zanchetti A; Leonetti G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S161-4. PubMed ID: 2442510
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells.
    Ko Y; Totzke G; Graack GH; Heidgen FJ; Meyer zu Brickwedde MK; Düsing R; Vetter H; Sachinidis A
    J Hypertens; 1993 Nov; 11(11):1171-8. PubMed ID: 8301097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses.
    van Zwieten PA; Pfaffendorf M
    J Hypertens Suppl; 1993 Dec; 11(6):S3-8. PubMed ID: 8169379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of verapamil and isradipine on steady-state digoxin kinetics.
    Rodin SM; Johnson BF; Wilson J; Ritchie P; Johnson J
    Clin Pharmacol Ther; 1988 Jun; 43(6):668-72. PubMed ID: 2967742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.